BrCC[N+]12CC[N+](CCBr)(CC1)C2.O=C([O-])[C@H](O)[C@@H](O)C(=O)[O-]
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?